Bluejay Diagnostics (BJDX) Enterprise Value (2020 - 2026)

Bluejay Diagnostics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$3.7 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 18.24% year-over-year to -$3.7 million; the TTM figure through Mar 2026 stood at -$3.7 million (down 18.24% YoY), while the FY2025 annual figure was -$5.2 million, down 20.06% from the prior year.
• Enterprise Value came in at -$3.7 million for Q1 2026 at Bluejay Diagnostics, up from -$5.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$2.2 million in Q4 2023 to a low of -$17.1 million in Q1 2022.
• A 5-year average of -$6.8 million and a median of -$5.1 million in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value sank 470.33% in 2022 and soared 78.17% in 2023, its largest moves.
• Bluejay Diagnostics' Enterprise Value stood at -$10.1 million in 2022, then jumped by 78.17% to -$2.2 million in 2023, then plunged by 94.79% to -$4.3 million in 2024, then retreated by 20.06% to -$5.2 million in 2025, then climbed by 28.66% to -$3.7 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$3.7 million, -$5.2 million, and -$3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison